China In Vitro Diagnostics Market Outlook to 2016

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2014 Update

Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • December 2014
  • 31 pages

Summary Biohit Oyj (Biohit) is a biotechnology company. The company develops manufactures and markets diagnostic tests and analysis system. Its products include acetaldehyde binding products, diagnostic tests, monoclonal antibodies, instruments and pipettes. Biohit develops and manufactures monoclonal ...

Industries: In Vitro Diagnostic | Countries: Germany, Finland, China

In Vitro Diagnostics Markets in China

In Vitro Diagnostics Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • December 2014
  • 168 pages

China's demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consume ...

Industries: In Vitro Diagnostic | Countries: China

A&T Corporation (Symbol:6722) SWOT Analysis, Strategy, Revenues and Profits

A&T Corporation (Symbol:6722) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. A&T Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: In Vitro Diagnostic | Countries: South Korea, Japan, Russian Federation, Taiwan, China

BioCurex, Inc. (Symbol:BOCX) SWOT Analysis, Strategy, Revenues and Profits

BioCurex, Inc. (Symbol:BOCX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BioCurex, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: In Vitro Diagnostic | Countries: Canada, United States, United Kingdom, China

Shanghai Fosun Medical Technology Development Co., Ltd. - Strategic SWOT Analysis Review

Shanghai Fosun Medical Technology Development Co., Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Shanghai Fosun Medical Technology Development Co., Ltd. (Shanghai Fosun) is a medical device company. The company produces vitro diagnostic (IVD) products. Its product portfolio consists of four product lines such as clinical chemistry reagents, microbiology, molecular diagnostic products, and ...

Industries: In Vitro Diagnostic | Countries: China

China Medical Technologies, Inc. - Strategic SWOT Analysis Review

China Medical Technologies, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary China Medical Technologies, (China Medical) is engaged in the development, manufacture and marketing of in-vitro diagnostics (IVD) products for the treatment of solid cancers and benign tumors. The company principally operates through its wholly owned subsidiaries, Beijing Yuande Bio-Medical ...

Industries: In Vitro Diagnostic | Countries: China

China Independent Clinical Laboratory Industry Report, 2014-2017

China Independent Clinical Laboratory Industry Report, 2014-2017

  • $ 1 850
  • Industry report
  • by Research In China
  • October 2014
  • 78 pages

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as 70% yr-on-yr, yet only accounting for 2%-3% of the total revenue ...

Industries: In Vitro Diagnostic | Countries: China

Diagnostic Reagent Markets in China

Diagnostic Reagent Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • October 2014
  • 193 pages

China's demand for Diagnostic Reagent has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consume ...

Industries: In Vitro Diagnostic | Countries: China

Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)

Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)

  • $ 1 495
  • Industry report
  • by Access China Management Consulting Ltd.
  • September 2014
  • 208 pages

Synopsis China's regulatory framework for in-vitro diagnostic reagents is undergoing earthshaking changes. It will bring overseas and multinational in-vitro diagnostic reagent manufacturers the maximum challenges and opportunities. How do you in compliance with the latest Chinese regulations on in-vitro ...

Industries: In Vitro Diagnostic | Countries: China

POCT Market in China 2014-2018

POCT Market in China 2014-2018

  • $ 2 500
  • Industry report
  • by Infiniti Research Limited
  • September 2014
  • 76 pages

About POCT POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases ...

Industries: In Vitro Diagnostic | Countries: China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.